Seattle Genetics,announced that Jonathan Drachman has been promoted to Chief Medical Officer and executive vice president, research and development. In this new role, he will lead the company’s clinical development and regulatory affairs teams, in addition to his continued oversight of research and translational medicine. Prior to joining Seattle Genetics, Drachman was associate professor in the hematology division, department of medicine at the University of Washington in Seattle, where he remains a clinical associate professor of medicine.
- Health Care Industry
- Seattle Genetics